Carlayne E. Jackson

9.9k total citations · 2 hit papers
85 papers, 3.5k citations indexed

About

Carlayne E. Jackson is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Carlayne E. Jackson has authored 85 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Neurology, 25 papers in Genetics and 15 papers in Molecular Biology. Recurrent topics in Carlayne E. Jackson's work include Amyotrophic Lateral Sclerosis Research (38 papers), Neurogenetic and Muscular Disorders Research (24 papers) and Peripheral Neuropathies and Disorders (11 papers). Carlayne E. Jackson is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (38 papers), Neurogenetic and Muscular Disorders Research (24 papers) and Peripheral Neuropathies and Disorders (11 papers). Carlayne E. Jackson collaborates with scholars based in United States, Canada and Italy. Carlayne E. Jackson's co-authors include Richard J. Barohn, Jeffrey Rosenfeld, Wilson W. Bryan, Edward J. Kasarskis, Hiroshi Mitsumoto, J. S. Katz, Wendy Johnston, Susan Woolley, Michael J. Strong and C. Shoesmith and has published in prestigious journals such as Neurology, Annals of Neurology and The Lancet Neurology.

In The Last Decade

Carlayne E. Jackson

78 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review)

2009 552 citations Carlayne E. Jackson, J. S. Katz et al. profile →
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review)

2009 438 citations Carlayne E. Jackson, Jeffrey Rosenfeld et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlayne E. Jackson United States	31	2.3k	1.2k	572	563	440	85	3.5k
Deborah Gelinas United States	32	2.3k 1.0×	1.3k 1.1×	516 0.9×	482 0.9×	93 0.2×	68	3.4k
Jonathan Katz United States	29	1.9k 0.8×	600 0.5×	448 0.8×	754 1.3×	352 0.8×	78	3.0k
T. L. Munsat United States	32	1.2k 0.5×	1.8k 1.5×	1.5k 2.7×	493 0.9×	155 0.4×	59	3.4k
C M Wiles United Kingdom	29	831 0.4×	190 0.2×	457 0.8×	392 0.7×	164 0.4×	56	3.2k
J. D. England United States	6	1.6k 0.7×	697 0.6×	126 0.2×	243 0.4×	77 0.2×	7	2.1k
David S. Younger United States	25	1.4k 0.6×	212 0.2×	365 0.6×	220 0.4×	196 0.4×	114	2.5k
Carmel Armon United States	27	1.6k 0.7×	620 0.5×	338 0.6×	432 0.8×	236 0.5×	77	2.7k
Hans Katzberg Canada	27	1.5k 0.7×	197 0.2×	258 0.5×	349 0.6×	320 0.7×	124	2.4k
Susana Pinto Portugal	29	1.5k 0.6×	1000 0.8×	228 0.4×	153 0.3×	99 0.2×	111	2.1k
Thomas Gattringer Austria	24	1.2k 0.5×	138 0.1×	537 0.9×	240 0.4×	1.2k 2.8×	110	3.5k

Countries citing papers authored by Carlayne E. Jackson

Since Specialization

Citations

This map shows the geographic impact of Carlayne E. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlayne E. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlayne E. Jackson more than expected).

Fields of papers citing papers by Carlayne E. Jackson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlayne E. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlayne E. Jackson. The network helps show where Carlayne E. Jackson may publish in the future.

Co-authorship network of co-authors of Carlayne E. Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Carlayne E. Jackson. A scholar is included among the top collaborators of Carlayne E. Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlayne E. Jackson. Carlayne E. Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Busis, Neil A., Janet Bickel, & Carlayne E. Jackson. (2025). Elevating the wellbeing of neurologists. The Lancet Neurology. 24(2). 99–99.

Meng, Lisa, Stacy A. Rudnicki, Andrew A. Wolff, et al.. (2023). Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS. Journal of Medical Economics. 26(1). 488–493. 2 indexed citations

Pattee, Gary L., Angela Genge, Philippe Couratier, et al.. (2023). Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis. Expert Review of Neurotherapeutics. 23(10). 859–866. 15 indexed citations

Meng, Lisa, Stacy A. Rudnicki, Andrew A. Wolff, et al.. (2022). MiToS and King’s staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 24(3-4). 304–310. 3 indexed citations

Lee, Dong Hwan, Joy N. Tsai, E. Sandra Chocrón, et al.. (2022). Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset. BMC Neurology. 22(1). 62–62. 33 indexed citations

Rose, Michael R., Reza Sadjadi, John Weinman, et al.. (2012). Role of disease severity, illness perceptions, and mood on quality of life in muscle disease. Muscle & Nerve. 46(3). 351–359. 57 indexed citations

Jackson, Carlayne E., et al.. (2008). Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity. Muscle & Nerve. 37(4). 473–476. 107 indexed citations

Jackson, Carlayne E., et al.. (2006). Factors correlated with NPPV use in ALS. Amyotrophic Lateral Sclerosis. 7(2). 80–85. 34 indexed citations

Szabó, C. Ákos, et al.. (2005). Vagal Nerve Stimulation: Clinical and Electrophysiological Effects on Vocal Fold Function. Annals of Otology Rhinology & Laryngology. 114(1). 7–14. 32 indexed citations

10.

Infante, Anthony J., Jacques Baillargeon, Ellen Kraig, et al.. (2003). Evidence of a diverse T cell receptor repertoire for acetylcholine receptor, the autoantigen of myasthenia gravis. Journal of Autoimmunity. 21(2). 167–174. 15 indexed citations

11.

Hassan, Erkan, et al.. (2002). Clinical practice guidelines for sustained neuromuscular blockade in the adult critically iii patient. American Journal of Health-System Pharmacy. 59(2). 179–195. 3 indexed citations

12.

Jackson, Carlayne E.. (2002). Vital capacity as an efficacy measure: Con. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 3(sup1). S59–S60. 2 indexed citations

13.

Wolfe, Gil I., Richard J. Barohn, Barbara M. Foster, et al.. (2002). Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis. Muscle & Nerve. 26(4). 549–552. 65 indexed citations

14.

Jackson, Carlayne E., Jeffrey Rosenfeld, Dan H. Moore, et al.. (2001). A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. Journal of the Neurological Sciences. 191(1-2). 75–78. 118 indexed citations

15.

Amato, Anthony A., et al.. (1997). Chronic relapsing brachial plexus neuropathy with persistent conduction block. Muscle & Nerve. 20(10). 1303–1307. 25 indexed citations

16.

Amato, Anthony A., Gary Gronseth, Carlayne E. Jackson, et al.. (1996). Inclusion body myositis: Clinical and pathological boundaries. Annals of Neurology. 40(4). 581–586. 139 indexed citations

17.

Adams, Kathleen K., et al.. (1996). Cervical Myelopathy With False Localizing Sensory Levels. Archives of Neurology. 53(11). 1155–1158. 10 indexed citations

18.

Jackson, Carlayne E., Richard J. Barohn, & Louis J. Ptáček. (1994). Paramyotonia congenita: Abnormal short exercise test, and improvement after mexiletine therapy. Muscle & Nerve. 17(7). 763–768. 51 indexed citations

19.

Mohan, Sumathy, Richard J. Barohn, Carlayne E. Jackson, & Keith A. Krolick. (1994). Evaluation of Myosin-Reactive Antibodies from a Panel of Myasthenia Gravis Patients. Clinical Immunology and Immunopathology. 70(3). 266–273. 21 indexed citations

20.

Block, Melvin A., Boy Frame, & Carlayne E. Jackson. (1978). The efficacy of subtotal parathyroidectomy for primary hyperparathyroidism due to multiple gland involvement.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 147(1). 1–5. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact